- All sections
- A - Human necessities
- A61B - Diagnosissurgeryidentification
- A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
Patent holdings for IPC class A61B 5/1486
Total number of patents in this class: 2320
10-year publication summary
136
|
180
|
163
|
257
|
190
|
221
|
235
|
209
|
187
|
106
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
DexCom, Inc. | 1659 |
460 |
Abbott Diabetes Care Inc. | 2029 |
336 |
Medtronic MiniMed, Inc. | 1805 |
266 |
Roche Diabetes Care, Inc. | 1505 |
125 |
F. Hoffmann-La Roche AG | 7939 |
72 |
Ascensia Diabetes Care Holdings AG | 600 |
59 |
Roche Diabetes Care GmbH | 623 |
45 |
PHC Holdings Corporation | 719 |
35 |
The Regents of the University of California | 20015 |
33 |
ARKRAY, Inc. | 870 |
26 |
California Institute of Technology | 3981 |
23 |
Bionime Corporation | 138 |
21 |
Verily Life Sciences LLC | 1584 |
20 |
One Health Biosensing Inc. | 43 |
20 |
Allez Health Inc. | 24 |
20 |
Terumo Kabushiki Kaisha | 5566 |
17 |
Medtrum Technologies Inc. | 353 |
17 |
Biolinq, Inc. | 131 |
14 |
Uxn Co., Ltd. | 32 |
14 |
PercuSense, Inc. | 34 |
14 |
Other owners | 683 |